Development Level

Tchem 7 | 1,890
Tbio 4 | 10,625
Tclin 2 | 602

IMPC Term

abnormal bone structure 1 | 131
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating phosphat... 1 | 15
decreased lean body mass 1 | 195
improved glucose tolerance 1 | 56
increased circulating HDL chol... 1 | 63
increased circulating alkaline... 1 | 119
increased circulating choleste... 1 | 53
increased circulating creatini... 1 | 29
increased circulating serum al... 1 | 25
increased fasted circulating g... 1 | 68
increased total body fat amoun... 1 | 57
preweaning lethality, complete... 1 | 633
small kidney 1 | 10

Disease

Cancer 10 | 2,346
lung cancer 10 | 4,466
osteosarcoma 10 | 7,933
Prostatic Neoplasms 9 | 471
ovarian cancer 9 | 8,484
psoriasis 9 | 6,685
Breast cancer 8 | 3,094
glioblastoma 7 | 5,572
lung adenocarcinoma 7 | 2,713
Mammary Neoplasms 6 | 410
interstitial cystitis 6 | 2,299
medulloblastoma, large-cell 6 | 6,234
non-small cell lung cancer 6 | 2,798
pancreatic cancer 6 | 2,300
atypical teratoid / rhabdoid tumor 5 | 4,369
cystic fibrosis 5 | 1,665
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,289
lung carcinoma 5 | 2,844
malignant mesothelioma 5 | 3,162
subependymal giant cell astrocytoma 5 | 2,287
ulcerative colitis 5 | 2,087
Arthritis 4 | 248
Multiple Sclerosis 4 | 498
Neoplastic Cell Transformation 4 | 81
adrenocortical carcinoma 4 | 1,427
adult high grade glioma 4 | 2,148
cutaneous lupus erythematosus 4 | 1,056
ductal carcinoma in situ 4 | 1,745
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
invasive ductal carcinoma 4 | 2,950
nasopharyngeal carcinoma 4 | 1,056
non-small cell lung carcinoma 4 | 413
pilocytic astrocytoma 4 | 3,086
pituitary cancer 4 | 1,972
primary Sjogren syndrome 4 | 789
primitive neuroectodermal tumor 4 | 3,031
sonic hedgehog group medulloblastoma 4 | 1,482
tuberculosis 4 | 1,557
Acquired immunodeficiency syndrome 3 | 164
Adenoma 3 | 165
Atherosclerosis 3 | 275
Atopic dermatitis 3 | 944
Cerebrovascular disease 3 | 231
Coronary artery disease 3 | 240
Eye disease 3 | 55
HIV Infections 3 | 100
Hypersensitivity reaction type II disease 3 | 235
Kidney disease 3 | 396
Li-Fraumeni Syndrome 3 | 13
Liver carcinoma 3 | 217
Lung disease 3 | 132
Male infertility 3 | 170
Multiple myeloma 3 | 1,327
Neoplasm Metastasis 3 | 138
Prostate cancer 3 | 172
Schizophrenia 3 | 501
Waldenstrons macroglobulinemia 3 | 765
breast carcinoma 3 | 1,614
colon cancer 3 | 1,475
diabetes mellitus 3 | 1,663
hepatocellular carcinoma 3 | 532
juvenile dermatomyositis 3 | 1,189
oligodendroglioma 3 | 2,849
pancreatic carcinoma 3 | 567
pediatric high grade glioma 3 | 2,712
periodontitis 3 | 269
posterior fossa group A ependymoma 3 | 1,511
posterior fossa group B ependymoma 3 | 1,530
sarcoidosis 3 | 358
Adenoid Cystic Carcinoma 2 | 99
Alzheimer's disease 2 | 644
Amyotrophic Lateral Sclerosis 2 | 431
Anemia 2 | 252
Brain Ischemia 2 | 87
Dementia 2 | 129
Dermatitis 2 | 107
Down syndrome 2 | 548
Endometriosis 2 | 535
Female infertility 2 | 28
Hepatitis B 2 | 103
Hypersensitivity 2 | 63
Hypertension 2 | 287
Hypertensive disease 2 | 193
IGA Glomerulonephritis 2 | 454
Influenza 2 | 142
Liver neoplasms 2 | 109
Pancreatic Neoplasm 2 | 79
Peripheral Neuropathy 2 | 303
Pneumonia 2 | 133
Polycystic Ovary Syndrome 2 | 332
Status Epilepticus 2 | 85
Stomach Neoplasms 2 | 282
astrocytoma 2 | 1,493
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
glioblastoma multiforme 2 | 347
head and neck cancer 2 | 270
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
mucosa-associated lymphoid tissue lymphoma 2 | 480
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795

Tissue

Blood and immune system 13 | 17,995
Cardiovascular System 13 | 17,958
Digestive Tract 13 | 18,473
Endocrine System 13 | 18,512
Female tissues 13 | 18,647
Liver and Pancreas 13 | 18,136
Male tissues 13 | 17,969
Nervous System 13 | 18,561
Respiratory system 13 | 17,484
Skin and soft tissues 13 | 18,115
Urinary Tract 13 | 18,444

Target Family

Enzyme 4 | 4,146
Non-IDG 4 | 11,971
Transcription Factor 3 | 1,400
GPCR 2 | 406

Grant Application

5P50CA069568-13 13 | 13
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
E3 ubiquitin-protein ligase Mdm2 MDM2 Tchem Enzyme -3.38438 2174.7 1062
C-X-C chemokine receptor type 4 CXCR4 Tclin GPCR -3.38245 2485.7 991
C-C motif chemokine 2 CCL2 Tchem Non-IDG -3.79323 6604.2 1001
ETS translocation variant 1 ETV1 Tbio Transcription Factor -2.08110 120.0 180
Stromal cell-derived factor 1 CXCL12 Tbio Non-IDG -3.41773 2853.2 486
C-C chemokine receptor type 2 CCR2 Tchem GPCR -3.00281 1034.3 447
Cellular tumor antigen p53 TP53 Tchem Transcription Factor -4.67490 51004.8 5255
Breast cancer type 1 susceptibility protein BRCA1 Tchem Non-IDG -3.72596 5756.8 1322
Bis(5'-adenosyl)-triphosphatase FHIT Tchem Enzyme -2.84474 769.7 412
Transmembrane protease serine 2 TMPRSS2 Tchem Enzyme -2.61069 408.7 182